| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |